<DOC>
	<DOCNO>NCT00472836</DOCNO>
	<brief_summary>CP-945,598 eliminate follow extensive metabolism . For drug , decrease renal ( kidney ) function affect elimination body via metabolism . This study therefore compare pharmacokinetics ( time course drug concentration body ) , safety tolerability CP-945,598 patient severe renal impairment healthy control subject .</brief_summary>
	<brief_title>Study Examining The Effect Of Renal Impairment On Safety , Toleration And How The Body Processes An Experimental Drug</brief_title>
	<detailed_description />
	<criteria>Normal Subjects : 1.Healthy . 2.Matched age ( ± 5 yr ) , weight ( ± 10 kg ) , gender ratio ( ± 2 subject per gender ) . Subjects Renal Disease : 1 . Severe impairment ( Creatinine clearance &lt; 30 mL/min ) 2 . Stable renal disease : change last 30 day . 3 . Stable dose medication and/or treatment . 4 . Reasonably wellcontrolled type 1 type 2 diabetic All subject : Nonprescribed use drug abuse/ recreational drug ; recent treatment experimental drug herbal experiment ; EKG blood pressure parameter fall outside protocolspecified limit ; history regular alcohol tobacco use exceed protocolspecified limit Normal subject : Medically important health condition ; recent use prescription nonprescription medication . Subjects renal disease : Subjects require dialysis ; certain chronic medical condition ; patient receive renal transplant ; severe and/or poorly control diabetes ; Treatment protocolspecified drug may alter way body absorbs process CP945,598 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>